TY - JOUR
T1 - PTPμ suppresses glioma cell migration and dispersal
AU - Burgoyne, Adam M.
AU - Palomo, Juan M.
AU - Phillips-Mason, Polly J.
AU - Burden-Gulley, Susan M.
AU - Major, Denice L.
AU - Zaremba, Anita
AU - Robinson, Shenandoah
AU - Sloan, Andrew E.
AU - Vogelbaum, Michael A.
AU - Miller, Robert H.
AU - Brady-Kalnay, Susann M.
PY - 2009/12
Y1 - 2009/12
N2 - The cell-surface receptor protein tyrosine phosphatase mu (PTPμ) is a homophilic cell adhesion molecule expressed in CNS neurons and glia. Glioblastomas (GBMs) are the highest grade of primary brain tumors with astrocytic similarity and are characterized by marked dispersal of tumor cells. PTPμ expression was examined in human GBM, low-grade astrocytoma, and normal brain tissue. These studies revealed a striking loss of PTPμ protein expression in highly dispersive GBMs compared to less dispersive low-grade astrocytomas and normal brain. We hypothesized that PTPμ contributes to contact inhibition of glial cell migration by transducing signals in response to cell adhesion. Therefore, loss of PTPμ may contribute to the extensive dispersal of GBMs. The migration of brain tumor cells was assessed in vitro using a scratch wound assay. Parental U-87 MG cells express PTPm and exhibited limited migration. However, short-hairpin RNA (shRNA)-mediated knockdown of PTPμ induced a morphological change and increased migration. Next, a brain slice assay replicating the three-dimensional environment of the brain was used. To assess migration, labeled U-87 MG glioma cells were injected into adult rat brain slices, and their movement was followed over time. Parental U-87 MG cells demonstrated limited dispersal in this assay. However, PTPμ shRNA induced migration and dispersal of U-87 MG cells in the brain slice. Finally, in a mouse xenograft model of intracranially injected U-87 MG cells, PTPμ shRNA induced morphological heterogeneity in these xenografts. Together, these data suggest that loss of PTPμ in human GBMs contributes to tumor cell migration and dispersal, implicating loss of PTPμ in glioma progression.
AB - The cell-surface receptor protein tyrosine phosphatase mu (PTPμ) is a homophilic cell adhesion molecule expressed in CNS neurons and glia. Glioblastomas (GBMs) are the highest grade of primary brain tumors with astrocytic similarity and are characterized by marked dispersal of tumor cells. PTPμ expression was examined in human GBM, low-grade astrocytoma, and normal brain tissue. These studies revealed a striking loss of PTPμ protein expression in highly dispersive GBMs compared to less dispersive low-grade astrocytomas and normal brain. We hypothesized that PTPμ contributes to contact inhibition of glial cell migration by transducing signals in response to cell adhesion. Therefore, loss of PTPμ may contribute to the extensive dispersal of GBMs. The migration of brain tumor cells was assessed in vitro using a scratch wound assay. Parental U-87 MG cells express PTPm and exhibited limited migration. However, short-hairpin RNA (shRNA)-mediated knockdown of PTPμ induced a morphological change and increased migration. Next, a brain slice assay replicating the three-dimensional environment of the brain was used. To assess migration, labeled U-87 MG glioma cells were injected into adult rat brain slices, and their movement was followed over time. Parental U-87 MG cells demonstrated limited dispersal in this assay. However, PTPμ shRNA induced migration and dispersal of U-87 MG cells in the brain slice. Finally, in a mouse xenograft model of intracranially injected U-87 MG cells, PTPμ shRNA induced morphological heterogeneity in these xenografts. Together, these data suggest that loss of PTPμ in human GBMs contributes to tumor cell migration and dispersal, implicating loss of PTPμ in glioma progression.
KW - Cell migration
KW - Dispersal
KW - Glioblastoma
KW - PTPμ
KW - Protein tyrosine phosphatase
UR - http://www.scopus.com/inward/record.url?scp=70449650636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449650636&partnerID=8YFLogxK
U2 - 10.1215/15228517-2009-019
DO - 10.1215/15228517-2009-019
M3 - Article
C2 - 19304959
AN - SCOPUS:70449650636
SN - 1522-8517
VL - 11
SP - 767
EP - 778
JO - Neuro-oncology
JF - Neuro-oncology
IS - 6
ER -